focus -WSS

focus

author：focus 2025-09-28 01:37:30 - browse：81512

A radiologist looks at X-rays on screen in a dark room — coverage from STAT — Adobe

Radiology has long led the way in the application of artificial intelligence in medicine. More than three-quarters of AI and machine learning devices authorized by the Food and Drug Administration work with medical images — and that dominance was evident at this year’s meeting of the Radiological Society of North America, where AI vendors gathered to tout their latest offerings.

“How clinical AI is changing radiology for good,” Philips promised to share in a sponsored session. Nuance, the AI-driven voice recognition company acquired by Microsoft last year for $16 billion, sponsored a lunch session on the promise of generative AI to “raise the bar on quality and efficiency,” echoing the frequent claim that AI can solve the plague of physician burnout and staff shortages.

But as pitches for the next generation of AI dominated the demonstration floor, there was tension between excitement and skepticism of the technology. The meeting’s scientific sessions reflected a more mixed reality — one marked with uncertainty and some concern about the real impact of AI tools on patient outcomes.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Medicare inequities exacerbate Puerto Rico’s health disparities

leisure time

WSS

Medicare threatens to cut off funding for HCA's Mission hospital

Antivenom research: Lessons from HIV applied in search for universal antidote

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Senators start work on Medicare physician payment reform

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

NIH study of ME/CFS points to clear biological hallmarks

hotspot

focus

hotspot

Alkermes shareholders re

Medicare inequities exacerbate Puerto Rico’s health disparities

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

6 phony surgeries that take placebo to the extreme

Heart attack and stroke risk calculators need revising

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

State Dept. review finds Biden bears some blame for Afghanistan failures

Antivenom research: Lessons from HIV applied in search for universal antidote

Alkermes shareholders re

New documents shed light on MD Anderson Cancer Institute feud

hotspot

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Medicare inequities exacerbate Puerto Rico’s health disparities

New documents shed light on MD Anderson Cancer Institute feud

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

What we’ve learned from the Aduhelm mess

Wikipedia

leisure time

knowledge

hotspot